Navigation Links
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis
Date:11/23/2009

blank' href="http://www.raptorpharma.com/patients_nash.html">non-alcoholic steatohepatitis ("NASH"), Huntington's Disease ("HD"), aldehyde dehydrogenase ("ALDH2") deficiency, and a non-opioid solution designed to potentially treat chronic pain.

Raptor's preclinical programs are based upon bioengineered novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein ("RAP") and related proteins that are designed to target cancer, neurodegenerative disorders and infectious diseases.

For additional information, please visit www.raptorpharma.com.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limited to the following statements: that Raptor will start a Phase 3 clinical trial in cystinosis patients at multiple US and European sites in the first quarter of 2010, if at all; that DR Cysteamine may allow for a 30% reduction in a patient's total daily cysteamine dose compared to the current standard of care; that DR Cysteamine can be administered in two doses per day instead of four, to achieve the same pharmacodynamic result; that tolerability of DR Cysteamine, as demonstrated in this study, potentially represents a major step forward in the care of cystinosis patients; that Raptor's formulation could result in greatly improved dosing compliance and better long-t
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
2. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
3. Raptor Pharmaceutical Expands Board of Directors
4. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
5. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
6. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
7. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
8. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
9. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Solutions, Inc. (NASDAQ: BLFS ), a leading developer, manufacturer ... and cryopreservation freeze media and precision thermal ... "Company"), announced that the Company is scheduled to present at ... is scheduled to present at the Conference at 1:30 p.m. ... Hotel in New York City and ...
(Date:5/22/2015)... , May 22, 2015 The ... the $13 billion global cardiac rhythm management device ... Kalorama found that Medtronic, St. Jude Medical, Boston ... 80% of this market segment. The healthcare market ... Markets , uses 2015 as a base year, ...
(Date:5/22/2015)... , May 22, 2015  The U.S. ... Zarxio (filgrastim-sndz) -- the first biosimilar product approved ... -- points toward growth in the contract manufacturing ... mainstream CMO industry is geared to the production ... produce major biopharmaceutical products. The healthcare market research ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... Va., June 3, 2011 Patient Advocate Foundation (PAF) is ... contribution enabling it to begin offering support to patients ... its Co-Pay Relief Program (CPR) on June 6, 2011 ... organization that seeks to safeguard patients through effective mediation ...
... ANTONIO, June 3, 2011 At the 2011 ... #6033) will address the increasing demand for molecular imaging ... in three directions: patient access, clinical utilization, and new ... Siemens (NYSE: SI ) is ...
Cached Medicine Technology:Patient Advocate Foundation Announces Additional Support for Patient Co-Pay Relief Program Serving Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients 2Siemens Expands Customer Return on Innovation at SNM 2011 2Siemens Expands Customer Return on Innovation at SNM 2011 3Siemens Expands Customer Return on Innovation at SNM 2011 4
(Date:5/25/2015)... According to a recently published report by iData ... fixation market is driven by an increase in fractures ... infection prevention technologies. As the population ages, prevalence of ... the largest total number of bone fixation procedures in ... a result, the average selling price (ASP) of hip ...
(Date:5/25/2015)... Join Fiona's Soccer Camp at Novato High School's ... Irish National Player, Fiona O'Sullivan will be on site to ... her coaching style. Fiona has three camps running this summer ... at Lynwood Elmentary School (June 15-19) and Hill Recreation Center ... 6th, 2015 - 1:00-3:00pm. Bring a Soccer Ball, Cleats and ...
(Date:5/24/2015)... 25, 2015 Pacific Prime has announced that they ... looking at the cost of individual international health insurance. Titled: ... looks at the cost of health insurance in six top expat ... Hong Kong , Singapore , ... UAE , the UK , Article 2 ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 Scientists with ... paper on air quality compliance issues that may have ... workers. Surviving Mesothelioma has just posted an article on ... , The group found airborne asbestos levels well ... collected between 1984 and 2011. , “Asbestos compliance sampling ...
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
Breaking Medicine News(10 mins):Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2
... March 25 Universal Benefit Plans--a Boston based, ... today that they will offer of a comprehensive ... no charge. Through their affiliate organization, Leggette Actuaries, ... COBRA notification, tracking and billing responsibilities for their ...
... write about benefits of running; top essayists honored at ... Financial services leader ING today selected three winners ... their accomplishments as participants in the ING Run For ... schools.The top three essays were submitted by the following ...
... Highly regarded Orange County plastic surgeon, Dr. Michael Niccole says there ... non-surgical treatments while taking time to research and do the homework ... ... Newport Beach, CA (PRWEB) March 25, 2009 -- Adapting one,s priorities ...
... in French . , A collaborative study ... University has demonstrated a positive link between cognitive ability and ... year olds. The correlation is evident in regions that integrate ... published this week in a special issue of scientific journal ...
... to announce the receipt of their official IRS determination letter. , ... ... ) is thrilled to announce the receipt of their official IRS determination ... serves and supports therapeutic massage and spa services for cancer patients ...
... urges new role in coordinating, funding local prevention efforts ... from private, nonprofit groups calls on the U.S. government ... mental health of the nation,s youth. , The ... asking President Barack Obama to create a new agency ...
Cached Medicine News:Health News:Universal Benefit Plans Teams up with Leggette Actuaries to Offer Free COBRA Services to New Clients 2Health News:ING Names Winners of 'ING Run For Something Better' Student Essay Contest 2Health News:ING Names Winners of 'ING Run For Something Better' Student Essay Contest 3Health News:ING Names Winners of 'ING Run For Something Better' Student Essay Contest 4Health News:ING Names Winners of 'ING Run For Something Better' Student Essay Contest 5Health News:Orange County Plastic Surgeon Warns: When It Comes To The Face And Body, The Best Deal Could Cost More 2Health News:When it comes to intelligence, size matters 2Health News:Angie's Spa Receives Official Acknowledgment of Non-Profit Status 2Health News:U.S. Asked to Do More for Kids' Mental Health 2Health News:U.S. Asked to Do More for Kids' Mental Health 3
Xsera Rapid HIV-1/2 Antibody Controls are unassayed positive and negative quality control materials used for monitoring the performance of qualitative rapid HIV-1 and HIV-2 test kits....
... a CLIA-certified diagnostic laboratory specializing in salivary ... number of other analytes in support of ... States. We also offer a diverse ... pre-clinical trials services. Our clients include ...
For the qualitative detection of igG antibodies specific to Helicobacter pylori in human serum, plasma and whole blood specimens...
For the qualitative detection of Infectious mononucleosis IgM heterophile antibodies in human whole blood, serum and plasma specimens....
Medicine Products: